Logo image of COUR

COURSERA INC (COUR) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:COUR - US22266M1045 - Common Stock

7.94 USD
+0.04 (+0.51%)
Last: 11/26/2025, 8:24:18 PM
7.94 USD
0 (0%)
After Hours: 11/26/2025, 8:24:18 PM
Fundamental Rating

5

COUR gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 77 industry peers in the Diversified Consumer Services industry. COUR has a great financial health rating, but its profitability evaluates not so good. COUR has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year COUR was profitable.
COUR had a positive operating cash flow in the past year.
In the past 5 years COUR always reported negative net income.
In multiple years COUR reported negative operating cash flow during the last 5 years.
COUR Yearly Net Income VS EBIT VS OCF VS FCFCOUR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

The Return On Assets of COUR (-4.60%) is comparable to the rest of the industry.
COUR has a Return On Equity of -7.16%. This is comparable to the rest of the industry: COUR outperforms 50.65% of its industry peers.
Industry RankSector Rank
ROA -4.6%
ROE -7.16%
ROIC N/A
ROA(3y)-13.24%
ROA(5y)-14.17%
ROE(3y)-19.16%
ROE(5y)-20.97%
ROIC(3y)N/A
ROIC(5y)N/A
COUR Yearly ROA, ROE, ROICCOUR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -10 -20 -30

1.3 Margins

COUR has a better Gross Margin (54.36%) than 64.94% of its industry peers.
In the last couple of years the Gross Margin of COUR has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for COUR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.81%
GM growth 5Y0.79%
COUR Yearly Profit, Operating, Gross MarginsCOUR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

8

2. Health

2.1 Basic Checks

COUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, COUR has more shares outstanding
The number of shares outstanding for COUR has been increased compared to 5 years ago.
COUR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
COUR Yearly Shares OutstandingCOUR Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
COUR Yearly Total Debt VS Total AssetsCOUR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

COUR has an Altman-Z score of 2.16. This is not the best score and indicates that COUR is in the grey zone with still only limited risk for bankruptcy at the moment.
COUR has a Altman-Z score of 2.16. This is in the better half of the industry: COUR outperforms 63.64% of its industry peers.
There is no outstanding debt for COUR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.16
ROIC/WACCN/A
WACC8.65%
COUR Yearly LT Debt VS Equity VS FCFCOUR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

COUR has a Current Ratio of 2.57. This indicates that COUR is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.57, COUR belongs to the best of the industry, outperforming 83.12% of the companies in the same industry.
A Quick Ratio of 2.57 indicates that COUR has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 2.57, COUR belongs to the best of the industry, outperforming 83.12% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.57
Quick Ratio 2.57
COUR Yearly Current Assets VS Current LiabilitesCOUR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

5

3. Growth

3.1 Past

COUR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 31.25%, which is quite impressive.
COUR shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.10%.
Measured over the past years, COUR shows a very strong growth in Revenue. The Revenue has been growing by 30.38% on average per year.
EPS 1Y (TTM)31.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)8.1%
Revenue growth 3Y18.71%
Revenue growth 5Y30.38%
Sales Q2Q%10.29%

3.2 Future

COUR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.08% yearly.
Based on estimates for the next years, COUR will show a small growth in Revenue. The Revenue will grow by 7.05% on average per year.
EPS Next Y17.21%
EPS Next 2Y15.91%
EPS Next 3Y18.08%
EPS Next 5YN/A
Revenue Next Year8.72%
Revenue Next 2Y7.35%
Revenue Next 3Y7.05%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
COUR Yearly Revenue VS EstimatesCOUR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
COUR Yearly EPS VS EstimatesCOUR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 18.90, the valuation of COUR can be described as rather expensive.
Based on the Price/Earnings ratio, COUR is valued a bit cheaper than the industry average as 64.94% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 26.15, COUR is valued a bit cheaper.
COUR is valuated rather expensively with a Price/Forward Earnings ratio of 17.38.
Based on the Price/Forward Earnings ratio, COUR is valued a bit cheaper than the industry average as 63.64% of the companies are valued more expensively.
COUR's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.12.
Industry RankSector Rank
PE 18.9
Fwd PE 17.38
COUR Price Earnings VS Forward Price EarningsCOUR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

COUR's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. COUR is cheaper than 72.73% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15.03
EV/EBITDA N/A
COUR Per share dataCOUR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

COUR's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
COUR's earnings are expected to grow with 18.08% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.1
PEG (5Y)N/A
EPS Next 2Y15.91%
EPS Next 3Y18.08%

0

5. Dividend

5.1 Amount

No dividends for COUR!.
Industry RankSector Rank
Dividend Yield N/A

COURSERA INC

NYSE:COUR (11/26/2025, 8:24:18 PM)

After market: 7.94 0 (0%)

7.94

+0.04 (+0.51%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)10-23 2025-10-23/amc
Earnings (Next)01-28 2026-01-28/amc
Inst Owners79.33%
Inst Owner Change5.47%
Ins Owners6.36%
Ins Owner Change-0.95%
Market Cap1.32B
Revenue(TTM)739.78M
Net Income(TTM)-45.81M
Analysts74.29
Price Target12.67 (59.57%)
Short Float %4.64%
Short Ratio2.48
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)26.72%
Min EPS beat(2)17.31%
Max EPS beat(2)36.12%
EPS beat(4)4
Avg EPS beat(4)48.89%
Min EPS beat(4)17.31%
Max EPS beat(4)92.38%
EPS beat(8)8
Avg EPS beat(8)1321.29%
EPS beat(12)12
Avg EPS beat(12)907.86%
EPS beat(16)14
Avg EPS beat(16)684.01%
Revenue beat(2)2
Avg Revenue beat(2)0.81%
Min Revenue beat(2)0.03%
Max Revenue beat(2)1.6%
Revenue beat(4)3
Avg Revenue beat(4)0.34%
Min Revenue beat(4)-0.48%
Max Revenue beat(4)1.6%
Revenue beat(8)5
Avg Revenue beat(8)0.04%
Revenue beat(12)9
Avg Revenue beat(12)0.94%
Revenue beat(16)12
Avg Revenue beat(16)0.73%
PT rev (1m)1.36%
PT rev (3m)1.36%
EPS NQ rev (1m)-12.76%
EPS NQ rev (3m)-14.58%
EPS NY rev (1m)1.48%
EPS NY rev (3m)11.63%
Revenue NQ rev (1m)2.11%
Revenue NQ rev (3m)2.11%
Revenue NY rev (1m)1.06%
Revenue NY rev (3m)1.38%
Valuation
Industry RankSector Rank
PE 18.9
Fwd PE 17.38
P/S 1.79
P/FCF 15.03
P/OCF 10.82
P/B 2.07
P/tB 2.15
EV/EBITDA N/A
EPS(TTM)0.42
EY5.29%
EPS(NY)0.46
Fwd EY5.75%
FCF(TTM)0.53
FCFY6.65%
OCF(TTM)0.73
OCFY9.24%
SpS4.45
BVpS3.84
TBVpS3.69
PEG (NY)1.1
PEG (5Y)N/A
Graham Number6.03
Profitability
Industry RankSector Rank
ROA -4.6%
ROE -7.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.36%
FCFM 11.88%
ROA(3y)-13.24%
ROA(5y)-14.17%
ROE(3y)-19.16%
ROE(5y)-20.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.81%
GM growth 5Y0.79%
F-Score5
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 121.61%
Cap/Sales 4.63%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.57
Quick Ratio 2.57
Altman-Z 2.16
F-Score5
WACC8.65%
ROIC/WACCN/A
Cap/Depr(3y)108%
Cap/Depr(5y)109.75%
Cap/Sales(3y)3.84%
Cap/Sales(5y)3.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)31.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y17.21%
EPS Next 2Y15.91%
EPS Next 3Y18.08%
EPS Next 5YN/A
Revenue 1Y (TTM)8.1%
Revenue growth 3Y18.71%
Revenue growth 5Y30.38%
Sales Q2Q%10.29%
Revenue Next Year8.72%
Revenue Next 2Y7.35%
Revenue Next 3Y7.05%
Revenue Next 5YN/A
EBIT growth 1Y34.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year259.82%
EBIT Next 3Y79.6%
EBIT Next 5YN/A
FCF growth 1Y1633.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y866.87%
OCF growth 3Y279.12%
OCF growth 5YN/A

COURSERA INC / COUR FAQ

What is the ChartMill fundamental rating of COURSERA INC (COUR) stock?

ChartMill assigns a fundamental rating of 5 / 10 to COUR.


What is the valuation status for COUR stock?

ChartMill assigns a valuation rating of 4 / 10 to COURSERA INC (COUR). This can be considered as Fairly Valued.


How profitable is COURSERA INC (COUR) stock?

COURSERA INC (COUR) has a profitability rating of 2 / 10.


How financially healthy is COURSERA INC?

The financial health rating of COURSERA INC (COUR) is 8 / 10.